These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 388854)

  • 1. Substance P: pharmacology, properties, and mode of action.
    Oehme P; Piesche L; Hilse H; Bergmann J; Hecht K; Nieba K; Bienert M
    Vopr Biokhim Mozga; 1978; 13():168-76. PubMed ID: 388854
    [No Abstract]   [Full Text] [Related]  

  • 2. Substance P--new aspect to its modulatory function.
    Oehme P; Hecht K; Piesche L; Hilse H; Poppei M; Morgenstern E; Göres E
    Acta Biol Med Ger; 1980; 39(4):469-77. PubMed ID: 6160707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The facilitation of the reproduction of a conditioned avoidance reaction by substance P in rats].
    Skarina TI; Loskutova LV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1991; 41(1):186-8. PubMed ID: 1711743
    [No Abstract]   [Full Text] [Related]  

  • 4. [Avoidance reaction in rats following dopamine administration to the neostriatum].
    Iakimovskiĭ AF
    Fiziol Zh SSSR Im I M Sechenova; 1980 Sep; 66(9):1312-8. PubMed ID: 7418912
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of the monoaminergic mechanisms of the dorsal hippocampus actualizing conditioned avoidance reactions in rats].
    Zin'kovskaia LIa; Komissarov IV; Talalaenko AN
    Biull Eksp Biol Med; 1974 Nov; 78(11):6-9. PubMed ID: 4447843
    [No Abstract]   [Full Text] [Related]  

  • 6. [The mechanism of the inhibitory influence of noradrenaline and serotonin on conditioned avoidance reactions in rats].
    Talalaenko AN
    Farmakol Toksikol; 1973; 36(5):517-20. PubMed ID: 4788056
    [No Abstract]   [Full Text] [Related]  

  • 7. [The dynamics of latent inhibition in rats under the action of substance P].
    Loskutova LV; Skarina TI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):543-8. PubMed ID: 1379770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological properties of the new vasodilator flosequinan.
    Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
    Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of dopamine in the mechanism of the sedative action of lithium salts].
    Zin'kovskaia LIa; Komissarov IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(3):426-30. PubMed ID: 1119285
    [No Abstract]   [Full Text] [Related]  

  • 10. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
    Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
    Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polypeptide "substance P": pathophysiologic aspects].
    Gomazkov OA
    Patol Fiziol Eksp Ter; 1980; (2):75-83. PubMed ID: 6156436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the effect of urapidil on the central nervous system and various organ functions in animal experiments (author's transl)].
    Schoetensack W; Eltze M; Gönne S; Kley KP; Menge HG; Müller H
    Arzneimittelforschung; 1977; 27(10):1898-907. PubMed ID: 579100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditioned-reflex learning of normal juvenile and adult rats exposed to action of substance P and of an SP analogue.
    Hecht K; Oehme P; Poppei M; Hecht T
    Pharmazie; 1979 Jul; 34(7):419-23. PubMed ID: 504332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of substance P on smooth musculature of the gastrointestinal tract (proceedings)].
    Nieber K; Milenov K; Oehme P; Bergmann J
    Pharmazie; 1979; 34(5-6):345-6. PubMed ID: 515151
    [No Abstract]   [Full Text] [Related]  

  • 15. Learning, brain noradrenaline and the pituitary--adrenal axis.
    Ogren SO; Fuxe K
    Med Biol; 1974 Dec; 52(6):399-405. PubMed ID: 4374613
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of alpha-adrenergic receptors at different levels of the central nervous system in the regulation of blood pressure and heart frequency.
    Trolin GG
    Acta Physiol Scand Suppl; 1975; 430():1-41. PubMed ID: 1064288
    [No Abstract]   [Full Text] [Related]  

  • 17. Central norepinephrine pathways are involved in cardiovascular response to intracerebroventricular substance P.
    Qian H; Yang LP; Wei ZY; Liu AD; Tian H; Yang SF
    Acta Pharmacol Sin; 2001 Apr; 22(4):349-54. PubMed ID: 11742588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of serotonin on the smooth muscles of the digestive vascular system in the rat and the guinea pig].
    Gawecka I; Kostowski W
    Acta Physiol Pol; 1966; 17(1):159-68. PubMed ID: 5917791
    [No Abstract]   [Full Text] [Related]  

  • 19. [Simulation of latent inhibition in rats by activation of the central serotoninergic system].
    Loskutova LV; Luk'ianenko FIa; Il'iuchenok RIu
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(6):1157-9. PubMed ID: 2629405
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interrelationship of the tranquilizers diazepam and lonetil with dopamine mediation in the central nervous system].
    Ovcharov R; Danchev N
    Eksp Med Morfol; 1981; 20(2):88-96. PubMed ID: 7250025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.